Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy
EULAR Rheumatology Open
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy. // EULAR Rheumatology Open. – URL: https://www.sciencedirect.com/science/article/pii/S3050708126001588?dgcid=rss_sd_all
Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy. EULAR Rheumatology Open. https://www.sciencedirect.com/science/article/pii/S3050708126001588?dgcid=rss_sd_all
“Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy.” EULAR Rheumatology Open.
@article{article44710,
title = {Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy},
journal = {EULAR Rheumatology Open},
url = {https://www.sciencedirect.com/science/article/pii/S3050708126001588?dgcid=rss_sd_all}
}